57 Two steroid hormone receptors and Y both contain a ligand binding domain recombinant DNA technology, a modified hybrid receptor H is prepared such that it contains the ligand binding domain of X and DNA binding domain of Y, three sets of cells overexpressing receptors X. Y and H were then treated separately ether With hormone X or with hormone Y- assuming that there is no cross— reactivity. which one of the following graphs best represent the receptor ligand binding in each case?

Steroid Receptor Hybrid Experiment: Understanding Ligand and DNA Binding Specificity
Introduction
Steroid hormone receptors function through distinct modular domains: a ligand-binding domain (LBD) that determines hormone specificity, and a DNA-binding domain (DBD) that determines gene regulatory targets. Recombinant DNA allows creation of hybrid receptors with domains swapped between receptors.
In this experiment, receptor X provides the LBD and receptor Y provides the DBD to form hybrid receptor H. Analysis of cells overexpressing X, Y, and H treated separately with hormones X or Y (which do not cross-react) reveals insights about receptor modularity and specificity.
Key Concepts
-
-
-
Receptor X: Has LBD specific to hormone X and own DBD.
-
Receptor Y: Has LBD specific to hormone Y and own DBD.
-
Hybrid receptor H: Contains LBD from X and DBD from Y.
-
-
Because hormones do not cross-react:
-
-
-
Hormone X activates receptors containing X’s LBD only (X and hybrid H).
-
Hormone Y activates receptors containing Y’s LBD only (Y).
-
-
Expected Binding and Activation Patterns
| Receptor | Hormone X Treatment | Hormone Y Treatment |
|---|---|---|
| X (native) | Activated (binds hormone X) | No activation (no Y LBD) |
| Y (native) | No activation (no X LBD) | Activated (binds hormone Y) |
| H (hybrid) | Activated (X LBD binds hormone X; Y DBD drives DNA binding) | No activation (X LBD cannot bind hormone Y) |
This predicts:
-
-
-
Hormone X activates X and H only.
-
Hormone Y activates only Y.
-
-
Graph Representation
A graph plotting receptor-ligand binding activity (y-axis) versus treatments (x-axis: hormone X, hormone Y) would show:
-
-
-
Receptor X: High activity with hormone X, near zero with hormone Y.
-
Receptor Y: High activity with hormone Y, near zero with hormone X.
-
Hybrid H: High activity only with hormone X.
-
-
Biological Implications
This experiment supports that the ligand specificity is conferred predominantly by the ligand-binding domain, while the DNA-binding domain determines transcriptional target specificity. The modular nature of nuclear receptors is fundamental for receptor engineering, drug design, and understanding gene regulation.



1 Comment
Divya rani
December 5, 2025Graph 3 is right.